CHF and CLBP are the main reasons I invested in Mesoblast - nothing disappoints me more than to see such a focus on GVHD while the two block buster treatments 'appear' to be sitting in the background with little progress ?
The CLBP trial needs to start this quarter as has continually been claimed by the company regardless of the FDA setback if the market is to have any confidence ?
As for the CHF FDA meeting ..... well this also needs to happen ? It has been more than 12 months since the FDA requested additional information on the CHF DREAM phase 3 trial and the meeting seems to have been postponed a few times - is this because the focus was on GVHD / Remestemcel-L .... who knows ?
Time for the company to deliver on multiple fronts
CEO Itescu needs to go, page-768
-
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |